V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220014749 | 220009362 | 1.8 | 58.4 | null | 2016-06-24 | 2016-07-15 | FIGARO TRIAL | N | N | 220035392 | IPILIMUMAB |
| 220014750 | 220009364 | 1.62 | 64.75 | Curative (C) | 2013-02-18 | 2013-02-25 | CISPLATIN + ETOPOSIDE | 02 | null | 220035392 | ALEMTUZUMAB + CYCLOPHOSPHAMIDE |
| 220014751 | 220014970 | 1.74 | 76 | Curative (C) | 2015-12-25 | 2015-12-25 | MidAC | N | N | 220035399 | EOX |
| 220014752 | 220014971 | null | null | Curative (C) | 2016-10-22 | 2016-10-31 | MidAC | N | null | 220035406 | ETOPOSIDE |
| 220014753 | 220009369 | 1.66 | 74.8 | Curative (C) | 2015-10-26 | 2015-10-28 | Alemtuzumab + Cyclophos TBI Allo | 02 | N | 220035412 | CAPECITABINE + OXALIPLATIN |
| 220014754 | 220009376 | 1.6 | 76 | Curative (C) | 2013-03-22 | 2013-10-21 | FLA | 2 | N | 220035414 | CARBOPLATIN |
| 220014755 | 220014974 | null | 62.3 | Curative (C) | 2013-05-04 | 2013-05-04 | DAUNORUBICIN | 01 | N | 220035417 | SPIRIT TRIAL |
| 220014756 | 220014974 | 1.73 | 6 | null | 2014-05-21 | 2014-07-22 | GCLAC | 2 | N | 220035417 | CAPECITABINE + TEMOZOLOMIDE |
| 220014757 | 220014974 | 1.64 | 115.4 | Palliative (P) | 2015-07-08 | 2015-08-25 | NIVOLUMAB | 01 | N | 220035417 | MACE |
| 220014758 | 220021595 | 1.52 | null | Disease modification (D) | 2018-01-02 | 2018-01-05 | Cisplatin +Fluorouracil (3 wk) | N | null | 220035422 | BORTEZOMIB + THALIDOMIDE |
| 220014759 | 220021595 | 1.68 | 78.5 | Disease modification (D) | 2018-03-11 | 2018-03-11 | Cisplatin + Pemetrexed | N | N | 220035422 | TRASTUZUMAB EMTANSINE |
| 220014761 | 220009385 | 1.62 | 83.2 | Disease modification (D) | 2013-06-07 | 2013-07-04 | CARBOPLATIN + RT | 2 | N | 220035446 | TRASTUZUMAB |
| 220014762 | 220014976 | null | 94.2 | Palliative (P) | 2017-10-27 | 2017-10-28 | Vinorelbine (oral) | 02 | N | 220035451 | ETOPOSIDE |
| 220014763 | 220014977 | null | null | Curative (C) | 2017-08-05 | 2017-08-06 | CHOP R - 21 days | N | N | 220035454 | CISPLATIN + PEMETREXED |
| 220014766 | 220009389 | 1.77 | 95.5 | Curative (C) | 2013-03-14 | 2013-03-29 | BENDAMUSTINE + RITUXIMAB | N | N | 220035476 | CETUXIMAB + RT |
| 220014769 | 220014983 | 1.76 | 76 | null | 2017-08-06 | 2017-08-06 | MITOXANTRONE + TRETINOIN | 01 | N | 220035490 | PEMBROLIZUMAB |
| 220014770 | 220009394 | 1.78 | 86 | Palliative (P) | 2016-12-09 | 2016-12-10 | IPM | N | N | 220035492 | EOX |
| 220014771 | 220009396 | 1.78 | 79.9 | null | 2013-12-10 | 2013-12-11 | Trifluridine + Tipiracil | N | null | 220035497 | MERCAPTOPURINE + METHOTREXATE |
| 220014772 | 220009398 | 1.64 | 74 | null | 2013-08-10 | 2013-09-28 | RAVVA TRIAL | 01 | N | 220035497 | PACLITAXEL + TRASTUZUMAB |
| 220014774 | 220014986 | 1.62 | 0 | Curative (C) | 2013-05-12 | 2013-06-09 | Bevacizumab | N | N | 220035508 | NIVOLUMAB |
| 220014775 | 220018178 | 1.67 | 62 | Palliative (P) | 2013-07-06 | 2013-07-30 | Capecitabine + Oxaliplatin 21day | 2 | N | 220035508 | CYTARABINE + IDARUBICIN |
| 220014776 | 220018178 | 1.77 | 106.2 | Curative (C) | 2016-09-27 | 2016-10-14 | MERCAPTOPURINE + METHOTREXATE | N | N | 220035508 | CISPLATIN + PEMETREXED |
| 220014780 | 220009407 | 1.84 | 72.4 | Curative (C) | 2017-10-11 | 2017-10-15 | Arsenic Trioxide (Induction Week) | 2 | N | 220035543 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB |
| 220014781 | 220009408 | null | 100 | Disease modification (D) | 2013-12-27 | 2014-10-16 | MELPHALAN | Y | Y | 220035549 | MITOXANTRONE + TRETINOIN |
| 220014782 | 220009412 | null | null | Disease modification (D) | 2016-12-09 | 2016-12-14 | CISPLATIN + RT | N | N | 220035566 | FLUDARABINE |
| 220014783 | 220009415 | 1.53 | 94 | Curative (C) | 2015-11-12 | 2016-02-26 | CARBOPLATIN + VINORELBINE | N | N | 220035570 | CAPECITABINE |
| 220014784 | 220009416 | 1.69 | 64 | Disease modification (D) | null | 2016-12-03 | MERCAPTOPURINE + METHOTREXATE | N | N | 220035571 | EOX |
| 220014785 | 220009416 | 1.53 | 84.4 | Curative (C) | 2016-05-15 | 2016-06-18 | IPM | N | N | 220035571 | MIDAC |
| 220014791 | 220009417 | 1.56 | 65.7 | Palliative (P) | 2015-07-16 | 2015-08-13 | CAPECITABINE + GEMCITABINE | N | N | 220035600 | EOX |
| 220014792 | 220009418 | 1.79 | null | Disease modification (D) | 2015-02-12 | 2015-02-19 | FIGARO TRIAL | 2 | N | 220035603 | MELPHALAN |
| 220014794 | 220014997 | 1.75 | 68 | Palliative (P) | 2015-01-27 | 2015-01-31 | CAP | N | N | 220035618 | UKALL 2011 |
| 220014795 | 220014997 | 1.65 | 125 | Palliative (P) | 2016-05-15 | 2016-05-27 | CYCLET | 02 | N | 220035618 | CAPECITABINE + GEMCITABINE |
| 220014796 | 220014997 | 1.67 | 78.4 | Palliative (P) | 2014-02-04 | 2014-06-11 | Cisplatin + Pemetrexed | N | N | 220035618 | GANETESPIB |
| 220014797 | 220021018 | 1.49 | 7.1 | Palliative (P) | 2015-02-16 | 2015-02-28 | Cisplatin + Etoposide (3 day) | 02 | N | 220035628 | LIPOSOMAL CYTARABINE |
| 220014798 | 220009422 | 1.81 | 66.8 | Not known (9) | 2015-08-25 | 2015-08-25 | Depocyte Intrathecal | Y | N | 220035628 | MIDAC |
| 220014799 | 220009422 | 1.03 | null | Palliative (P) | 2014-07-09 | 2014-08-09 | FLUDARABINE | N | N | 220035628 | CARBOPLATIN |
| 220014800 | 220009426 | 1.78 | null | Palliative (P) | 2016-10-14 | 2017-01-13 | BUSULFAN + CYCLO | null | null | 220035638 | MELPHALAN |
| 220014801 | 220009427 | 1.9 | 76.3 | Palliative (P) | null | 2016-06-19 | SPIRIT TRIAL | N | N | 220035638 | IFOSFAMIDE |
| 220014802 | 220009428 | 1.49 | 96.8 | Palliative (P) | 2018-09-23 | 2018-09-24 | Cisplatin + Pemetrexed | N | null | 220035645 | CARBOPLATIN |
| 220014803 | 220015000 | null | null | Curative (C) | 2017-04-29 | 2017-04-29 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | 220035650 | EOF |
| 220014804 | 220015000 | 1.73 | 71 | Curative (C) | 2016-08-11 | 2016-08-11 | DABRAFENIB + TRAMETINIB | 02 | N | 220035650 | ERLOTINIB |
| 220014805 | 220009429 | 1.7 | 47 | Palliative (P) | 2016-01-12 | 2016-01-24 | Arsenic Triox + Tretinoin Ind W1-4 | 2 | N | 220035657 | CLOFARABINE + CYTSARABINE + IDARUBICIN |
| 220014806 | 220015001 | 0 | 88 | Curative (C) | 2015-04-10 | 2015-08-30 | Pemetrexed | N | N | 220035659 | IPILIMUMAB |
| 220014807 | 220015001 | 1.7 | 77.7 | null | 2015-06-28 | 2015-07-03 | FLUDARABINE | N | null | 220035659 | CAPECITABINE + TEMOZOLOMIDE |
| 220014808 | 220015001 | 1.6 | 55.8 | Curative (C) | 2013-07-20 | 2013-07-20 | EOX | 02 | N | 220035659 | DOXORUBICIN |
| 220014809 | 220009430 | 1.65 | 66.5 | null | 2015-05-18 | 2015-05-18 | Carboplatin AUC 2 - 5 | 2 | N | 220035672 | FLUDARABINE |
| 220014810 | 220018189 | null | null | Palliative (P) | 2013-10-22 | 2013-11-26 | EOX | N | null | 220035685 | CISPLATIN + FLUOROURACIL |
| 220014811 | 220018189 | 1.76 | null | Palliative (P) | 2017-12-03 | 2017-12-14 | MERCAPTOPURINE + METHOTREXATE + VINCRISTINE | 2 | N | 220035685 | CISPLATIN + RT |
| 220014812 | 220018189 | 1.69 | null | Not known (9) | 2017-08-13 | 2017-08-14 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | 220035685 | CARBOPLATIN |
| 220014813 | 220018189 | 1.6 | 55 | Palliative (P) | 2014-10-16 | 2014-10-16 | Bevacizumab 5mg/kg | 02 | N | 220035685 | SUNITINIB |